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Lentiviruses in general and the human immunodeficiency virus type 1 (HIV-1) in particular have the ability to integrate their
genome stably into the chromosome of nondividing cells. Integration of HIV cDNA is mediated by the viral integrase (IN).
Apart from its catalytic activity, this enzyme seems to play an important role in the transport of the HIV preintegration
complex into the nucleus of nondividing cells. We studied the karyophilic properties of IN by constructing an N-terminal
fusion protein of HIV-1 integrase and green fluorescent protein (GFP-IN). Transient expression of GFP-IN in various
mammalian cell lines was demonstrated by fluorescence microscopy, flow cytometry, and Western blotting. Although
wild-type GFP was localized throughout the cell, GFP-IN was localized predominantly in the nucleus. Nuclear localization of
GFP-IN was also obtained after transient transfection of the cells arrested in the G1/S phase of the cell cycle. These results
































Integration is an essential step in the retroviral repli-
ation cycle. The only viral enzyme required for efficient
ntegration of the retroviral cDNA is integrase (IN), a
rotein of 32 kDa encoded by the 39-end region of the pol
ene (for a review, see Brown, 1997). The enzyme is
roduced by protease-mediated cleavage of the gag-pol
recursor during virion maturation. The IN recognizes
pecific sequences in the long terminal repeat elements
f the viral cDNA. The terminal 15 bp of the long terminal
epeat is necessary and sufficient for site-specific cleav-
ge and integration. A highly conserved dinucleotide CA
epeat immediately upstream of the cleavage site is
ritical for enzymatic activity (Sherman and Fyfe, 1990; La
emina et al., 1992). In the first step of the integration
eaction, termed 39-end processing, two nucleotides are
emoved from each 39-end to produce new 39-hydroxyl
nds (CA-39OH). This reaction occurs in the cytoplasm,
ithin a large viral nucleoprotein complex referred to as
he preintegration complex (Miller et al., 1997). After
ntering the nucleus, the processed viral double-
tranded DNA is joined to host target DNA. The joining
eaction involves the coordinated 4- to 6-bp staggered
leavage of the target host DNA and the ligation of
rocessed CA-39OH viral DNA ends to the 59 phosphate
nds of the cleaved target DNA. Gap repair, although not
ell understood at this time, probably is accomplished
y host-cell DNA repair enzymes, although IN might
arry out a cleavage–ligation reaction (Chow et al., 1992).
1 To whom reprint requests should be addressed at Minderbroeders-
traat 10, B-3000 Leuven, Belgium. Fax: 32-16-332131. E-mail: zeger.
ebyser@uz.kuleuven.ac.be.327ligonucleotide-based assays have been designed to
imic both processing and joining reactions in vitro
Bushman et al.,; 1990; Katz et al., 1990). These assays
ave been instrumental in elucidating the biochemistry
f the reactions carried out by IN.
In contrast to other retroviruses, the lentiviruses such
s the human immunodeficiency virus type 1 (HIV-1)
ave the capacity to replicate efficiently in nondividing
nd differentiated cells; thus nondividing mucosal den-
ritic cells and terminally differentiated macrophages
lay important roles in the pathogenesis of HIV infection
Finzi and Siciliano, 1998). Lentiviral integration requires
ransport of the preintegration complex through the nu-
lear membrane pores via an active, energy-dependent
rocess (Bukrinsky et al., 1992). The role of various viral
roteins in this process is not well understood. At least
hree components of the HIV-1 preintegration complex
eem to play a role in nuclear transport: Vpr (Heinzinger
t al., 1994; Fouchier et al., 1998; Popov et al., 1998),
atrix protein (Bukrinsky et al., 1993; Gallay et al., 1995),
nd IN (Gallay et al., 1997). These different proteins
nteract with each other and with the cellular import
achinery. The nuclear localization of Vpr and matrix
rotein is already well defined. The karyophilic proper-
ies of IN are not well established. IN of avian sarcoma
irus was expressed in eukaryotic cell lines as such
Morris-Vasios et al., 1989) or as a C-terminal fusion
rotein with b-galactosidase (Kukolj et al., 1997). A stable
urine cell line expressing Rous sarcoma virus IN has
lso been reported (Mumm et al., 1992). In these in-
tances, IN was found localized in the nucleus. Conflict-
ng data have been presented with respect to HIV-1 IN.
n HIV-1 IN–b-galactosidase fusion was expressed in0042-6822/99 $30.00
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328 PLUYMERS ET AL.he cytoplasm (Kukolj et al., 1997), whereas a fluores-
ein-conjugated recombinant protein in which IN was
used to the C-terminus of glutathione S-transferase,
njected into the cytoplasm of COS cells, localized almost
xclusively in the nucleus (Gallay et al., 1997). The inter-
ction between IN and karyopherin-a was required for
uclear import and was mediated by the recognition of a
ipartite nuclear localization signal in the IN protein
Gallay et al., 1997).
We constructed a fusion protein of HIV-1 IN and green
luorescent protein (GFP-IN) to address directly the
aryophilic properties of HIV-1 IN. The presence of GFP
nables direct visualization of the expressed protein by
luorescence microscopy. In accord with the data of
allay et al. (1997), we found that GFP-IN was localized
redominantly in the nucleus of transiently transfected
ells. Our results demonstrate that HIV-1 IN has the
ropensity to migrate into the nucleus.
RESULTS
xpression of GFP-IN
Transient transfection of 293T cells with the plasmid
EGFP-IN resulted in the expression of GFP-IN as ana-
yzed by fluorescence microscopy (Fig. 1). As a control,
xpression of GFP from the plasmid pEGFP-C2 was
erified in parallel. With both plasmids, 293T cells could
e transfected with a transfection efficiency of about
5%. The percentage of fluorescent cells correlated with
he transfection efficiency as measured by parallel trans-
ections of a b-galactosidase reporter plasmid (data not
hown). However, in all cells examined, the intensity of
he fluorescent signal was much lower in cells express-
ng the fusion protein in comparison with cells express-
ng GFP.
To prove that the fluorescence in the cells transfected
ith pEGFP-IN was really due to the presence of the
usion protein and not to GFP itself, we performed a
estern blot of a lysate of transiently transfected 293T
ells (Fig. 2). A 60-kDa protein was detected with anti-
odies to HIV-1 IN (lane 4 in Fig. 2A), whereas in the
ysate of the cells transfected with pEGFP-C2, no specific
ands were detected. The antibody recognizes recombi-
ant his-tagged HIV-1 IN (about 33 kDa) (lane 2 in Fig.
A). When the same lysates were analyzed with poly-
lonal antibodies directed against GFP, a protein of 27
Da was detected in the cells transfected with pEGFP-C2
lane 3 in Fig. 2B). The fusion protein GFP-IN was not
etected in this blot. Probably the affinity of the antibod-
es to GFP is not high enough to detect the low-level
xpression of GFP-IN.
uclear localization of GFP-IN in HeLa, OST/TK2, and
93T cells
The expression of GFP-IN and GFP was visualized in
ifferent cell lines by fluorescence microscopy (Fig. 1).e used HeLa (carcinoma), OST/TK (osteosarcoma),
nd 293T cells (transformed embryonic kidney cells) for
his purpose. Although GFP was present in both the
ytoplasm and the nucleus of the three cell lines exam-
ned, the GFP-IN fusion protein was predominantly lo-
ated in the nucleus. The presence of GFP in the nucleus
s likely due to diffusion [because the protein has a
olecular size (27 kDa) below the exclusion limit of the
ucleopore], but the nuclear localization of GFP-IN points
o karyophilic determinant(s) in the HIV-1 IN. The pres-
nce of a fluorescent label allowed us to determine the
inetics of GFP-IN production and nuclear transport. At
4 h post-transfection, GFP-IN was predominantly local-
zed in the cytoplasm. At 48 h post-transfection, nuclear
ocalization of GFP-IN was evident. Closer investigation
evealed that GFP-IN was not distributed homoge-
eously in the nucleus because in some cells, the pro-
ein seemed to be condensed into discrete loci (Fig. 1,
ight). In rare cells, spots of intense fluorescence were
bserved in the cytoplasm as well, most probably as a
esult of precipitation of GFP-IN expressed at high levels.
ocalization of GFP-IN in nondividing cells
The presence of GFP-IN in the nuclei of transfected
ells may be the result of the DNA-binding activity of IN
n cells during mitosis and nuclear membrane disassem-
ly. To rule out this possibility, transfection was per-
ormed in arrested 293T and OST/TK2 cells. Cells were
rrested in the G1/S phase of the cell cycle by aphidi-
holin treatment before transfection. Again, GFP-IN was
lmost exclusively localized in the nucleus of transfected
ells (data not shown).
xpression of HIV-1 IN quantified by FACS analysis
Attempts to express detectable levels of HIV-1 IN by
loning RRE behind IN and coexpressing Rev have failed
o far. The expression of HIV-1 IN as a fusion construct
ith GFP was a strategy for expressing HIV-1 IN in
ukaryotic cells that worked in our hands. The expres-
ion of HIV-1 IN is likely hampered by instability se-
uences that are known to exist in the transcribed mRNA
f the IN gene (Schneider et al., 1997). The following
xperiment illustrates the destabilizing effect of the IN
RNA on GFP expression. HeLa cells were transfected
ith pEGFP-IN or pEGFP-C2 by electroporation, and the
ercentage of fluorescent cells was determined by flow
ytometry (Fig. 3). Although transfection efficiency, ex-
ressed as percentage of fluorescent cells, was similar
39% versus 41% or 33% versus 32%, in the two experi-
ents shown in Fig. 3), mean fluorescence intensity in
he analyzed cells was about fivefold lower in the cells
xpressing GFP-IN compared with the cells expressing
FP.
a329NUCLEAR LOCALIZATION OF HIV-1 INTEGRASEFIG. 1. Expression of GFP and GFP-IN in different cell lines. Transient expression of GFP (left) and GFP-IN (right) in HeLa, OST/TK2, and 293T cells





















































330 PLUYMERS ET AL.DISCUSSION
We provide conclusive evidence for the nuclear local-
zation of HIV-1 IN, expressed as a N-terminal fusion
rotein with GFP in HeLa, OST/TK2, and 293T cells. This
esult is at odds with the finding of the cytoplasmic
ocalization of a C-terminal fusion protein of HIV-1 IN with
-galactosidase expressed transiently in HeLa-Tat cells
Kukolj et al., 1997). Because the same authors also
eported on the nuclear localization of a similar avian
arcoma virus IN–b-galactosidase fusion, the size of the
usion protein cannot be a limiting factor for nuclear
FIG. 2. Transient expression of GFP and GFP-IN in 293T cells.
ysates were made of 293T cells transiently expressing GFP or GFP-IN
nd analyzed by Western blotting. Lanes 3 and 4 each represent 24,000
ells. (A) Polyclonal antibodies directed against his-tagged HIV-1 IN
ere used. Lane 1 indicates rainbow protein molecular weight marker;
ane 2, 5 ng of his-tagged HIV-1 IN; lane 3, lysate of cells transfected
ith pEGFP-C2; and lane 4, lysate of cells transfected with pEGFP-IN.
B) Polyclonal antibodies directed against EGFP were used. Lanes 2–4
ndicate the same as in A.
FIG. 3. Quantification of GFP-IN expression using FACS analysis. He
ere fixed and analyzed by flow cytometry. An analysis of two separate r
ntensity and the percentage of fluorescent cells are indicated in eachmport. However, fusion to the C-terminus of IN might
revent correct folding and interfere with the interaction
f the bipartite nuclear localization signal of HIV-1 IN and
aryopherin-a (Gallay et al., 1997). HIV-1 IN contains
hree putative NLS sequences: KELKK160, KRK188, and
ELQKQITK219 (Myers et al., 1992). The two latter se-
uences were proposed to constitute a bipartite signal
hat binds to karyopherin-a (Gallay et al., 1997). We
onstructed an N-terminal fusion product with IN that
herefore should not interfere with the C-terminal NLS
equence.
Nuclear import of a fluorescein-conjugated glutathione-
-transferase–IN fusion protein was demonstrated previ-
usly (Gallay et al., 1997). In this experiment, however, IN
as not expressed endogenously, but instead recombinant
rotein was injected in the cytoplasm of COS-7 cells. Here
e show that IN, expressed in various mammalian cell
ines, is imported into the nucleus. The size of GFP (27 kDa)
s below the exclusion limit (40 kDa) of the nuclear pore
omplex (NPC). This implicates that GFP can enter the
ucleus without active transport and will be distributed
hroughout the cell. The size of GFP-IN (60 kDa) is well
bove the exclusion limit of the NPC. Passive diffusion of
he protein into the nucleus is prevented by the NPC;
herefore, without a specific transport mechanism through
he NPC, the protein would be excluded from the nucleus.
evertheless, we observed an accumulation of GFP-IN in
he nucleus that points to (1) an active transport through the
PC and to (2) a functional NLS in the IN protein. The
istribution of GFP-IN in the nucleus was not homoge-
eous, and the protein appeared to concentrate at discrete
oci. High-density fluorescent spots that were observed in
he cytoplasm of some cells may represent intracellular
recipitates of GFP-IN.
s transiently expressing GFP or GFP-IN or control HeLa cells (MOCK)





































































































331NUCLEAR LOCALIZATION OF HIV-1 INTEGRASEThe expression of the gag, pol, and env genes of HIV-1
n mammalian cells depends on the presence of the viral
ev protein (Smith et al., 1990; Cochrane et al., 1991;
yers et al., 1992). Expression of HIV-1 IN is hampered
y the presence of inhibitory or instability sequences
hroughout the IN gene (Schwartz et al., 1992; Schneider
t al., 1997). The presence of the Rev responsive element
RRE) downstream of the IN gene and Rev is believed to
ircumvent this instability to some extent (Cochrane et
l., 1991; Faust et al., 1995; Schneider et al., 1997). When
N was expressed as a fusion protein with Vpr, to trans-
omplement IN in virions lacking IN, it was also neces-
ary to introduce the RRE and to coexpress Rev (Fletcher
t al., 1997; Liu et al., 1997; Wu et al., 1997). In contrast to
hese observations, in our hands expression of IN as a
usion protein did not require Rev coexpression (data not
hown). This is in accordance with Kukolj et al. (1997),
ho expressed IN as a C-terminal fusion protein with
-galactosidase in the absence of Rev. Creation of the
FP-IN fusion was in our hands a successful approach
o express detectable levels of wild-type HIV-1 IN in
ammalian cells. Moreover, the presence of GFP en-
bles quantitative analysis by flow cytometry and opens
he possibility to perform biophysical studies in vivo on
he interaction of HIV-1 IN with DNA. The expression of
FP-IN can also be useful to develop a cellular integra-
ion assay and to study the enzymatic activity of IN in
ivo; such an assay should be helpful in the identification




The open reading frame of the HXB2 HIV-1 IN was PCR
mplified using the Pfu DNA polymerase (Stratagene)
ith the primers IN-LEFT (59-CCCCCAAGCTTGCCAGC-
ATGTTTTTAGATGGAATAGATAAGG-39) and IN-RIGHT
59-CCCGCTCGAGCTTTCCTTGAAATATACATATGGTG-39)
nd subcloned in pCEP4 (InVitrogen), resulting in pCEP-
N. The 1-kb HindIII–XhoI fragment of pCEP-IN contain-
ng the IN gene was cloned in the vector pEGFP-C2
Clontech) to obtain pEGFP-IN. This construct contains
he gene of the EGFP-IN chimera (EGFP fused to the
-terminus of the HIV-1 IN, which will be further denoted
FP-IN) under the control of the human immediate-early
ytomegalovirus enhancer/promoter. The full IN open
eading frame was sequenced to confirm the absence of
utations. No frameshift mutation or stop codon was
ntroduced behind the EGFP gene, as verified by DNA
equence analysis of the fusion part of both genes.
ell culture and transfections
The 293T cells (obtained from O. Danos, Evry, France)
ere grown in DMEM (GIBCO BRL) with glutamax sup-
lemented with 10% FCS, 500 U/ml penicillin, and 500g/ml streptomycin solution. Cells were seeded onto
-well plates at a density of 100,000 cells/well 24 h
efore transfection. On the day of transfection, 5 mg of
NA was diluted in 100 ml of 150 mM sterile NaCl. Then,
3.5 ml of EXGEN 500 (polyethyleneimine) (Euromedex,
trasbourg) was diluted in 75 ml of 150 mM NaCl. Both
olutions were mixed and incubated for 15 min at room
emperature. During this incubation, the cells were
ashed once with DMEM (GIBCO BRL) plus glutamax
nd 1% FCS, and 600 ml of this medium was used to
over the cells. After incubation, the DNA–polycation
omplexes were added dropwise to the cells, and the
lates were put in a 5% CO2 incubator. The day after
ransfection, the medium was changed with complete
MEM with 25 mM HEPES.
HeLa cells were grown in DMEM (GIBCO BRL) sup-
lemented with 10% FCS, 0.12% (v/w) sodium bicarbonate
GIBCO BRL), 2 mM glutamine (GIBCO BRL), and 20
g/ml gentamicin (GIBCO BRL). For electroporation, the
ells were trypsinized at 80% confluence and were pel-
eted by low-speed centrifugation. The cells were then
esuspended at a density of 2 3 106 cells/ml in growth
edium; 0.5 ml of this solution was aliquoted into 4-mm
uvettes (Eurogentec, Seraing, Belgium), and 20 mg of
NA was added to the cell suspension. After the electric
ulse (10 mF, 250 V), the cells were allowed to rest for 10
in at room temperature before plating.
The human osteosarcoma cell line OST/TK2 (ATCC
RL-8303) was grown in MEM (GIBCO BRL) supple-
ented with 10% FCS, 0.12% (v/w) sodium bicarbonate, 2
M glutamine, and 20 mg/ml gentamicin. The day before
ransfection, the cells were seeded onto a 35-mm dish
2.5 3 105 cells/dish). The transfection procedure was
dentical to that of 293T cells using the appropriate me-
ium for this cell line.
ell cycle arrest with aphidicholin
Cells were grown on 6-well plates as described above.
t a confluence of 40%, aphidicholin (Sigma) was added
o the medium at a final concentration of 15 mg/ml. At
4 h after this treatment, cells were transfected as de-
cribed above. Growth arrest by aphidicholin was veri-
ied in separate control experiments by cell counting.
estern blot analysis
At 48 h post-transfection, cells were lysed in SDS–
AGE loading buffer (25 mM Tris–HCl, pH 6.8, 50 mM
TT, 1% SDS, 0.05% bromophenol blue, and 5% glycerol)
t 3000 cells/ml. After the samples were boiled for 5 min,
ml was loaded onto a 15% SDS-polyacrylamide gel.
etection was performed on PVDF membranes (Bio-Rad)
sing the ECL1 chemiluminescent system (Amersham-
harmacia) with rabbit polyclonal anti-HIV-1 IN (pro-














































332 PLUYMERS ET AL.luorescence microscopy
At 48 h post-transfection, cells were washed twice
ith PBS, covered with a coverslip, and analyzed using
he Nikon fluorescence microscope, with the filter set at
2 (DM510; Nikon), to visualize the expression of EGFP
nd EGFP-IN.
ACS analysis
At 48 h post-transfection, cells were washed twice
ith PBS and subsequently fixed with 5% paraformalde-
yde (Sigma) in PBS. Cells were analyzed with an FAC-
can (Becton Dickinson Immunocytometry Systems, San
ose, CA). Data were acquired and analyzed with
ellQuest software (Becton Dickinson).
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